A Study to Evaluate Patient Satisfaction With the Overall Face and Neck Appearance After Combined Treatment of OnabotulinumtoxinA, JUVÉDERM® Products, KYBELLA, CoolSculpting Elite and SkinMedica Products

Inclusion Criteria: Applies to All Participants: * Must meet at least 1 of the following criteria for BOTOX UFL treatment per investigator's assessment: * Moderate or severe on Allergan Glabellar Line Severity Scale at maximum furrow * Moderate or severe on Forehead Line Severity Scale at maximum brow elevation and Moderate or Severe on Allergan Glabellar Line Severity Scale at maximum furrow * Moderate or severe on Lateral Canthal Line Severity Scale at maximum contraction (identical severity on both sides) * Must meet at least 3 of the following criteria for treatment in the face with at least 2 JUVÉDERM products, per investigator's assessment: * Moderate or severe on Allergan Loss of Jawline Definition Scale * Moderate or severe on Allergan Chin Retrusion Scale * Moderate, significant, or severe on Midface Volume Deficit Scale * Moderate or severe on Nasolabial Fold Severity Scale * Moderate or severe for both eyes on Allergan Infraorbital Hollows Scale * Minimal, mild, or moderate on 5-point Allergan Lip Fullness Scale * Moderate or severe on Allergan Cheek Smoothness Scale * Minimal, moderate, or severe on Allergan Temple Hollowing Scale Applies only to participants who will be treated for submental fullness: \- Moderate or severe on the Clinician-reported Submental Fat Rating Scale (for KYBELLA treatment) or Moderate, severe, or extreme (For CoolSculpting Elite treatment) per investigator's assessment. Exclusion Criteria: * History of medic…